Showing 1,941 - 1,960 results of 2,009 for search '(( ct ((values decrease) OR (largest decrease)) ) OR ( a ((laser decrease) OR (linear decrease)) ))', query time: 0.63s Refine Results
  1. 1941

    Data_Sheet_1_Association of glymphatic system dysfunction with cognitive impairment in temporal lobe epilepsy.docx by Jiajia Wang (157207)

    Published 2024
    “…Correlation analyses found that SVF performance was significantly or borderline significantly associated with glymphatic function (FDR-corrected p < 0.05 for all DTI-ALPS index and FDR-corrected p = 0.057 for CPV) in TLE patients. Linear regression analyses showed that increased CPV and decreased DTI-ALPS index were independent risk factors for semantic fluency impairment (all p < 0.05). …”
  2. 1942

    PVD neurons show reduced lysosome function during aging and in the <i>hlh-30</i> mutant. by Ruiling Zhong (22339779)

    Published 2025
    “…<p><b>(A–D)</b> A fluorescent reporter for luminal acidity of neuronal lysosomal compartments shows that acidity decreases with aging and in the <i><i>hlh-30</i></i> mutant. …”
  3. 1943

    Image 3_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  4. 1944

    Table 2_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  5. 1945

    Image 2_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  6. 1946

    Image 11_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  7. 1947

    Image 7_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  8. 1948

    Image 8_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  9. 1949

    Image 6_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  10. 1950

    Image 4_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  11. 1951

    Image 9_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  12. 1952

    Image 12_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  13. 1953

    Image 1_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.jpeg by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  14. 1954

    Table 3_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  15. 1955

    Image 13_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  16. 1956

    Table 1_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  17. 1957

    Image 10_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  18. 1958

    Image 5_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

    Published 2025
    “…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”
  19. 1959

    Baumer-TPW_2023_Dopamine-Monocytes_PMID37251548.xlsx by Tiffany Powell-Wiley (18098425)

    Published 2025
    “…Indicative of D2-signaling, cAMP levels were found to be lower in DA-treated monocytes compared to</p><p dir="ltr">untreated controls (control 29.78 pmol/ml vs DA 22.97 pmol/ml; p =0.038) and the impact of DA on NCM CCR2</p><p dir="ltr">expression was abrogated by co-treatment with 8-CPT, a cAMP analog. Furthermore, Filamin A (FLNA), a</p><p dir="ltr">prominent actin-crosslinking protein, that is known to regulate CCR2 recycling, significantly decreased in DA-</p><p dir="ltr">treated NCM (p < 0.05), indicating a reduction of CCR2 recycling. …”
  20. 1960

    Table 1_Association between combined urinary phthalate metabolites exposure and grip strength among residents in Guangzhou, China.docx by Jinbin Chen (4468570)

    Published 2025
    “…To assess these relationships, we conducted generalized linear regression models, Bayesian Kernel Machine Regression (BKMR), and Weighted Quantile Sum (WQS) regression analyses.…”